Personalized bacteriophage therapy for difficult-to-treat infections

被引：0
|
作者：
Iredell, Jonathan [1 ,2 ,3 ]
Sinclair, Holly [1 ,2 ,3 ]
Khatami, Ameneh [1 ,3 ,4 ]
机构：
[1] Westmead Inst Med Res, Ctr Infect Dis & Microbiol, Sydney, NSW, Australia
[2] Western Sydney Local Hlth Dist, Westmead Hosp, Sydney, NSW, Australia
[3] Univ Sydney, Sydney, NSW, Australia
[4] Sydney Childrens Hosp Network, Sydney, NSW, Australia
来源：
NATURE MICROBIOLOGY | 2024年
关键词：
D O I：
10.1038/s41564-024-01712-y
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
A real-world study of 100 diverse cases facilitated by a single centre for individualized bacteriophage therapy demonstrates feasibility and provides new hope for refractory and resistant bacterial infections.
引用
收藏
页码：1401 / 1402
页数：2
相关论文
共 50 条
  • [1] DIFFICULT-TO-TREAT INFECTIONS
    DEMARIE, S
    [J]. INTENSIVE CARE MEDICINE, 1990, 16 : S239 - S242
  • [2] Optimization of bacteriophage therapy for difficult-to-treat musculoskeletal infections: a bench-to-bedside perspective
    Bessems, Laura
    Chen, Baixing
    Uyttebroek, Saartje
    Devolder, David
    Lood, Cedric
    Verwimp, Stefaan
    De Munter, Paul
    Debaveye, Yves
    Depypere, Melissa
    Spriet, Isabel
    Van Gerven, Laura
    Dupont, Lieven
    Wagemans, Jeroen
    van Noort, Vera
    Lavigne, Rob
    Metsemakers, Willem-Jan
    Onsea, Jolien
    [J]. FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2024, 14
  • [3] Bacteriophage Therapy for Difficult-to-Treat Infections: The Implementation of a Multidisciplinary Phage Task Force (The PHAGEFORCE Study Protocol)
    Onsea, Jolien
    Uyttebroek, Saartje
    Chen, Baixing
    Wagemans, Jeroen
    Lood, Cedric
    Van Gerven, Laura
    Spriet, Isabel
    Devolder, David
    Debaveye, Yves
    Depypere, Melissa
    Dupont, Lieven
    De Munter, Paul
    Peetermans, Willy E.
    van Noort, Vera
    Merabishvili, Maia
    Pirnay, Jean-Paul
    Lavigne, Rob
    Metsemakers, Willem-Jan
    [J]. VIRUSES-BASEL, 2021, 13 (08):
  • [4] Phage therapy in pediatrics: the way forward for difficult-to-treat infections?
    Howard-Jones, Annaleise R.
    Iredell, Jonathan R.
    Khatami, Ameneh
    [J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2022, 20 (04) : 487 - 491
  • [5] OFLOXACIN THERAPY OF DIFFICULT-TO-TREAT INFECTIONS DUE TO MULTIRESISTANT ORGANISMS
    ELBAZ, W
    OSMAN, L
    ABDELHAMID, T
    ELBOKL, M
    SABBOUR, MS
    [J]. CHEMIOTERAPIA, 1987, 6 (02): : 129 - 133
  • [6] CHEMOTHERAPEUTIC POSSIBILITIES IN DIFFICULT-TO-TREAT INFECTIONS
    WILLIAMS, JD
    [J]. INFECTION, 1980, 8 (06) : 309 - 313
  • [7] Bacteriophage Application for Difficult-To-Treat Musculoskeletal Infections: Development of a Standardized Multidisciplinary Treatment Protocol
    Onsea, Jolien
    Soentjens, Patrick
    Djebara, Sarah
    Merabishvili, Maia
    Depypere, Melissa
    Spriet, Isabel
    De Munter, Paul
    Debaveye, Yves
    Nijs, Stefaan
    Vanderschot, Paul
    Wagemans, Jeroen
    Pirnay, Jean-Paul
    Lavigne, Rob
    Metsemakers, Willem-Jan
    [J]. VIRUSES-BASEL, 2019, 11 (10):
  • [8] Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review
    Uyttebroek, Saartje
    Chen, Baixing
    Onsea, Jolien
    Ruythooren, Fred
    Debaveye, Yves
    Devolder, David
    Spriet, Isabel
    Depypere, Melissa
    Wagemans, Jeroen
    Lavigne, Rob
    Pirnay, Jean-Paul
    Merabishvili, Maya
    De Munter, Paul
    Peetermans, Willy E.
    Dupont, Lieven
    Van Gerven, Laura
    Metsemakers, Willem-Jan
    [J]. LANCET INFECTIOUS DISEASES, 2022, 22 (08): : E208 - E220
  • [9] USE OF CEFOXITIN SODIUM IN DIFFICULT-TO-TREAT INFECTIONS
    NAIR, SR
    CHERUBIN, CE
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1978, 4 : 167 - 178
  • [10] USE OF INTRAVENOUS CIPROFLOXACIN IN DIFFICULT-TO-TREAT INFECTIONS
    GIAMARELLOU, H
    GALANAKIS, N
    [J]. AMERICAN JOURNAL OF MEDICINE, 1987, 82 (4A): : 346 - 351
12345